These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35380063)

  • 41. [Screening for neonatal inborn errors of metabolism by electrospray ionization-tandem mass spectrometry and follow-up].
    Huang XW; Yang JB; Tong F; Yang RL; Mao HQ; Zhou XL; Huang XL; Yang LL; Huang CG; Zhao ZY
    Zhonghua Er Ke Za Zhi; 2011 Oct; 49(10):765-70. PubMed ID: 22321184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of a novel, commercially available mass spectrometry kit for newborn screening including succinylacetone without hydrazine.
    Metz TF; Mechtler TP; Merk M; Gottschalk A; Lukačin R; Herkner KR; Kasper DC
    Clin Chim Acta; 2012 Aug; 413(15-16):1259-64. PubMed ID: 22521492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of Inborn Errors of Metabolism in Newborn Infants: Five Years' Single-Center Experience, Jeddah, Saudi Arabia.
    Al Qurashi M; Alahmadi S; Mustafa A; Aga SS; Al Hindi M; Ahmed A; Mohammad H; ElSharabasy R; Abed S; AlThubaiti I; Alrashdi N
    Clin Pediatr (Phila); 2023 Dec; 62(12):1523-1530. PubMed ID: 37908170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Newborn screening for congenital hypothyroidism, galactosemia and biotinidase deficiency in Uttar Pradesh, India.
    Gopalakrishnan V; Joshi K; Phadke S; Dabadghao P; Agarwal M; Das V; Jain S; Gambhir S; Gupta B; Pandey A; Kapoor D; Kumar M; Bhatia V
    Indian Pediatr; 2014 Sep; 51(9):701-5. PubMed ID: 25228601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inborn errors of metabolism in a tertiary care hospital of eastern India.
    Lodh M; Kerketta A
    Indian Pediatr; 2013 Dec; 50(12):1155-6. PubMed ID: 24413507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of Tandem Mass Spectrometry and the Fluorometric Method-Parallel Phenylalanine Measurement on a Large Fresh Sample Series and Implications for Newborn Screening for Phenylketonuria.
    Perko D; Groselj U; Cuk V; Iztok Remec Z; Zerjav Tansek M; Drole Torkar A; Krhin B; Bicek A; Oblak A; Battelino T; Repic Lampret B
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
    Fingerhut R
    Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A quantitative method for acylcarnitines and amino acids using high resolution chromatography and tandem mass spectrometry in newborn screening dried blood spot analysis.
    Miller JH; Poston PA; Karnes HT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():142-9. PubMed ID: 22846691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective screening for inborn errors of metabolism by tandem mass spectrometry at Sohag University Hospital, Egypt.
    Magdy RM; Abd-Elkhalek HS; Bakheet MA; Mohamed MM
    Arch Pediatr; 2022 Jan; 29(1):36-43. PubMed ID: 34848132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Newborn Thyroid Screening: Influence of Pre-Analytic Variables on Dried Blood Spot Thyrotropin Measurement.
    Butler AM; Charoensiriwatana W; Krasao P; Pankanjanato R; Thong-Ngao P; Polson RC; Snow G; Ehrenkranz J
    Thyroid; 2017 Sep; 27(9):1128-1134. PubMed ID: 28810813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The first pilot study of expanded newborn screening for inborn errors of metabolism and survey of related knowledge and opinions of health care professionals in Hong Kong.
    Mak CM; Law EC; Lee HH; Siu WK; Chow KM; Au Yeung SK; Ngan HY; Tse NK; Kwong NS; Chan GC; Lee KW; Chan WP; Wong SF; Tang MH; Kan AS; Hui AP; So PL; Shek CC; Lee RS; Wong KY; Yau EK; Poon KH; Siu S; Poon GW; Kwok AM; Ng JW; Yim VC; Ma GG; Chu CH; Tong TY; Chong YK; Chen SP; Ching CK; Chan AO; Tam S; Lau RL; Ng WF; Lee KC; Chan AY; Lam CW
    Hong Kong Med J; 2018 Jun; 24(3):226-237. PubMed ID: 29888706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of birth weight on profiles of dried blood amino-acids and acylcarnitines.
    Yang L; Zhang Y; Yang J; Huang X
    Ann Clin Biochem; 2018 Jan; 55(1):92-99. PubMed ID: 29064274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of 2-methylcitric acid, methylmalonic acid, and total homocysteine in dried blood spots by LC-MS/MS for application in the newborn screening laboratory: A dual derivatization approach.
    Dubland JA; Rakić B; Vallance H; Sinclair G
    J Mass Spectrom Adv Clin Lab; 2021 Apr; 20():1-10. PubMed ID: 34820666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling.
    Jiang X; Tang F; Feng Y; Li B; Jia X; Tang C; Liu S; Huang Y
    J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1253-1258. PubMed ID: 31603856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Newborn screening for carnitine palmitoyltransferase II deficiency using (C16+C18:1)/C2: Evaluation of additional indices for adequate sensitivity and lower false-positivity.
    Tajima G; Hara K; Tsumura M; Kagawa R; Okada S; Sakura N; Maruyama S; Noguchi A; Awaya T; Ishige M; Ishige N; Musha I; Ajihara S; Ohtake A; Naito E; Hamada Y; Kono T; Asada T; Sasai H; Fukao T; Fujiki R; Ohara O; Bo R; Yamada K; Kobayashi H; Hasegawa Y; Yamaguchi S; Takayanagi M; Hata I; Shigematsu Y; Kobayashi M
    Mol Genet Metab; 2017 Nov; 122(3):67-75. PubMed ID: 28801073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Screening of newborns for inborn errors of metabolism by tandem mass spectrometry].
    Simonsen H
    Ugeskr Laeger; 2002 Nov; 164(48):5607-12. PubMed ID: 12523003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Expand newborn screening using tandem mass spectrometry: two years' experience in Nuevo León, Mexico].
    Torres-Sepúlveda Mdel R; Martínez-de Villarreal LE; Esmer C; González-Alanís R; Ruiz-Herrera C; Sánchez-Peña A; Mendoza-Cruz JA; Villarreal-Pérez JZ
    Salud Publica Mex; 2008; 50(3):200-6. PubMed ID: 18516367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of mass spectrometry in newborn screening: about both small molecular diseases and lysosomal storage diseases.
    Hwu WL; Chien YH; Lee NC; Wang SF; Chiang SC; Hsu LW
    Top Curr Chem; 2014; 336():177-96. PubMed ID: 22911488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of second-tier testing on the effectiveness of newborn screening.
    Chace DH; Hannon WH
    Clin Chem; 2010 Nov; 56(11):1653-5. PubMed ID: 20837783
    [No Abstract]   [Full Text] [Related]  

  • 60. Useful second-tier tests in expanded newborn screening of isovaleric acidemia and methylmalonic aciduria.
    Shigematsu Y; Hata I; Tajima G
    J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S283-8. PubMed ID: 20440648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.